^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NVG-111

    i
    Other names: NVG-111, NG I, NG II, NG III, NG IV, NVG 111, NVG111
    Company:
    Novalgen
    Drug class:
    CD3 agonist, ROR1 inhibitor
    Related drugs:
    Apply
    First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies (NVG111-101) (NCT04763083)
    Phase 1
    NovalGen Ltd.
    Recruiting
    Last update posted :
    07/07/2023
    Initiation :
    05/14/2021
    Primary completion :
    12/01/2023
    Completion :
    12/01/2025
    ROR1
    |
    NVG-111